PERTUSSIS (WHOOPING COUGH)

 

PERTUSSIS (WHOOPING COUGH)

 

DEFINITION:

An acute bacterial infection of the lower respiratory tract characterized by a paroxysmal cough.

EPIDEMIOLOGY:

  • prevalence: 10/100,000
  • age of onset:
    • all, but 50% before 2 years and 35% before 6 months of age
  • risk factors:
    • endemic and epidemic every 2-4 years
    • non-immunized children
    • history of contact

PATHOGENESIS:

1. Etiology

1. Bacterial Pathogen

  • Bordetella pertussis (gram negative bacilli)

2. Pathogenesis

  • spread: airborne droplet
  • incubation period: 6 to 20 days and usually 7-10 days
  • infectivity: 1 week before the onset of the paroxysmal cough and 3 weeks after (maximal in Catarrhal Stage)
  • duration of illness: 6-10 weeks in uncomplicated cases
  • a whooping cough syndrome may also be caused by:
    • Bordetella parapertussis - adenoviruses 1,2, & 5
    • Bordetella bronchiseptica - CMV
    • Chlamydia trachomatis

CLINICAL FEATURES:

1. Catarrhal Stage

  • lasts 7-10 days
  • prodrome of mild upper respiratory tract symptoms:
    • anorexia and listlessness
    • cough - hacking and nocturnal
    • coryza and rhinorrhea
    • inflammed mucous membranes
    • insidious and most contagious stage

2. Paroxysmal Stage

  • lasts a mean of 10-14 days but can last up to 6-10 weeks
  • paroxysmal cough
    • characterized by 5-15 rapid coughs followed by a characteristic inspiratory whoop, a few normal breaths and then more of the same (chronic cough)
    • paroxysms initially occur at night and then become more frequent during the day (5-50 episodes per day)
    • the face may become suffused or cyanotic during an episode
    • paroxysms of coughing often end in vomiting
    • may be associated with copious amounts of viscid fluid leading to aspiration and vomiting
    • fever absent or minimal

3. Convalescent Stage

  • lasts 2-4 weeks and sometimes months
  • paroxysmal cough
    • not as frequent or severe as in the paroxysmal stage
    • symptoms gradually wane but may last for 6 months
    • with each URI for up to a year after the acute infection, many children will develop a pertussis-like cough

4. Atypical Manifestations

1. Infants

  • less than 6 months of age
  • may present with apnea with no inspiratory whoop

2. Older Children and Adults

  • persistent cough and no inspiratory whoop
  • disease in older children and those vaccinated is often milder

5. Complications*

1. Neurological

  • seizures (+/- intracranial bleeds)
  • encephalopathy (seizures and mental retardation)

2. Respiratory

  • apnea, cyanosis,
  • pneumonia (aspiration, atelectasis, consolidation)

3. Gastrointestinal

  • rectal prolapse

4. Others

  • inguinal hernia
  • nose bleeds
  • subconjunctival hemorrhages
  • secondary bacterial infections (otitis media, sinusitis)

5. Death

  • increased mortality in those less than 2 years of age
  • case-fatality rate is 0.5% in those less than 6 months

 

  • *more common in those less than 1 year
  • INVESTIGATIONS

    1. Diagnosis

    1. Nasopharyngeal Aspirate

    • culture is positive in only 80% of cases
    • most frequently positive in the catarrhal or early paroxysmal stages and rarely found after the 4th week of illness
    • rapid direct immunofluorescence testing has variable sensitivity and specificity

    2. Imaging Studies

    1. Chest X-Ray

    • to rule out pneumonia

    3. Serum

    • CBC - lymphocytosis a nonspecific finding

    MANAGEMENT:

    1. Medical

    1. Antibiotics

    • aim is to prevent spread of infection to other family members as the effect on the severity and duration of the illness is minor
    • all family members with children under the age of 7 should also be treated

    1. Erythromycin Estolate (Ilosone)

    • 40-50 mg/kg/d po qid (max. 2gm/d) x 14 days

    2. Trimethoprim-Sulfamethoxazole (Septra)

    • 2.5 cc po bid (less than 2 years)
    • 2.5-5.0 cc po bid (2-5 years)
    • 5-10 cc po bid (6-12 years)

    2. Hospitalization

    • for supportive care for those with severe illness and complications, i.e., apnea moniter, feeding difficulties, oxygen, periodic gentle nasal suctioning, hydration
    • should be placed in respiratory isolation for 5 days after initiation of antibiotic therapy

     

     

     

    Pediatric Database - PERTUSSIS (WHOOPING COUGH)

    Pediatric Organization - Pedbase [at] Gmail.com